What are the possible adverse reactions of ibrutinib/ibrutinib?

Ibrutinib/Ibrutinib is a commonly used anti-cancer drug, mainly used to treat certain types of leukemia and lymphoma. However, like other medications, ibrutinib may cause some side effects. The following is a detailed introduction to the possible side effects of ibrutinib:

Ibrutinib may cause an increase in bleeding tendency. Patients may experience symptoms such as epistaxis, gum bleeding, and gastrointestinal bleeding. This is because ibrutinib may affect the blood coagulation mechanism, leading to a decrease in coagulation function. Therefore, while using ibrutinib, patients need to pay close attention to their bleeding and report any abnormal bleeding symptoms to their doctor in a timely manner.

Ibrutinib may also affect the immune system and increase the risk of infection. Common infections include upper respiratory tract infections, urinary tract infections, and lung infections. This is because ibrutinib may suppress the normal function of the immune system, making the body more susceptible to bacteria and viruses. Therefore, while taking ibrutinib, patients need to pay special attention to personal hygiene, avoid contact with sources of infection, and seek prompt medical treatment for any symptoms of infection.

In addition, ibrutinib may also cause some cardiovascular reactions, such as hypertension, arrhythmia, and heart failure. These side effects may pose a potential threat to patients' cardiovascular health. Therefore, during the use of ibrutinib, patients need to regularly monitor physiological indicators such as blood pressure and heart rate, and follow the doctor's recommendations for necessary treatment and management.

In addition to the above-mentioned side effects, ibrutinib may also cause some skin reactions, such as rash, itching, and dryness. Some patients may also experience symptoms such as edema or skin inflammation. Although these skin reactions are not usually life-threatening, they can cause discomfort and distress to the patient. Therefore, while using ibrutinib, patients need to pay close attention to their skin conditions and promptly report any abnormal symptoms to their doctor.